SSAI statement supports the suspension of HES solutions by the EMA

The European Medicine Agency has decided to suspend Hydroxyethyl-Starch (HES) because of serious side-effects in specific patient groups: This decision has obviously led to some discussion, especially among those who have continued to use HES despite concerns about safety.This discussion…









